BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24061983)

  • 1. [Multimodality management of squamous cell carcinoma of thoracic esophagus].
    Wang ZX; Mao T; Guo XF; Fang WT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):815-8. PubMed ID: 24061983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
    Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
    Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
    Cao XF; He XT; Ji L; Xiao J; Lv J
    Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
    Tanaka A; Ishikawa S; Okuno K; Shiozaki H
    Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
    Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
    Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of preoperative radio-chemotherapy in locally advanced squamous epithelial cancer of the esophagus].
    Nürnberger HR; Löffler T; Hausamen TU; Theophil B; Löhlein D
    Chirurg; 1993 Sep; 64(9):701-7; discussion 707-8. PubMed ID: 8222927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy for squamous cell esophageal carcinoma.
    Fink U; Stein HJ; Bochtler H; Roder JD; Wilke HJ; Siewert JR
    Ann Oncol; 1994; 5 Suppl 3():17-26. PubMed ID: 8204527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
    Lu JC; Tao H; Chen ZZ; Qian PD
    Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
    Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
    Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and Prognostic Analysis of Adjuvant Radiotherapy versus Salvage Radiotherapy for Treatment of Radically Resected Locally Advanced Esophageal Squamous Cell Carcinoma.
    Xu X; Xie HY; Zhou D; Huang RH; Bai YR; Yuan J; Ye M
    Biomed Res Int; 2016; 2016():8548694. PubMed ID: 27822478
    [No Abstract]   [Full Text] [Related]  

  • 12. [Concomitant chemoradiotherapy of cancer of the esophagus].
    Calais G
    Cancer Radiother; 1998 Dec; 2(6):689-95. PubMed ID: 9922774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical efficacy of consolidation chemotherapy for resectable esophageal squamous cell cancer after trimodality therapy.
    Sun Y; Cheng S; Lu Y; Zheng X; Ye K; Ge H
    J Cancer Res Ther; 2016; 12(1):90-5. PubMed ID: 27072217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors of recurrence and metastasis in pN1 stage squamous cell carcinoma of the thoracic esophagus after radical esophagectomy with lymphadenectomy].
    Guo XF; Mao T; Ji CY; Gu ZT; Chen WH; Fang WT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):831-4. PubMed ID: 24061987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].
    Wang YX; Yang Q; He M; Qiu R; Li J; Zhu SC; Qiao XY; Qi Z
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):48-55. PubMed ID: 28104034
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodality treatments with endoscopic mucosal resection of esophageal squamous cell carcinoma with submucosal invasion.
    Ota M; Ide H; Hayashi K; Murata Y; Eguchi R; Nakamura T; Narumiya K; Oi I; Takasaki K
    Surg Endosc; 2003 Sep; 17(9):1429-33. PubMed ID: 12802668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.